HealthcareGlobal
Ticker > Company >

HealthcareGlobal share price

Healthcare Global Enterprises Ltd.

NSE: HCG BSE: 539787 SECTOR: Hospital & Healthcare Services  56.28 K   152   38

733.65
+0.80 (0.11%)
BSE: 17 Oct 04:01 PM

Price Summary

Today's High

₹ 744.55

Today's Low

₹ 707.45

52 Week High

₹ 744.55

52 Week Low

₹ 405.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 10344.47 Cr.

Enterprise Value

₹ 10731.62 Cr.

No. of Shares

14.1 Cr.

P/E

0

P/B

8.81

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  83.26

CASH

₹ 264.14 Cr.

DEBT

₹ 651.29 Cr.

Promoter Holding

62.46 %

EPS (TTM)

₹  -0.55

Sales Growth

9.04%

ROE

0.3 %

ROCE

6.03%

Profit Growth

-89.25 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Healthcare Global Enterprises Ltd.

HCG Milann Strand Life Sciences

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.04%
3 Year14.52%
5 Year13.15%

Profit Growth

1 Year-89.25%
3 Year-54.82%
5 Year15.62%

ROE%

1 Year0.3%
3 Year2.26%
5 Year-3.04%

ROCE %

1 Year6.03%
3 Year7.1%
5 Year3.84%

Debt/Equity

0.5571

Price to Cash Flow

70.88

Interest Cover Ratio

1.2327

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.46 5.70
Mar 2025 71.22 4.99
Dec 2024 71.23 3.09
Sep 2024 71.23 3.09
Jun 2024 71.25 3.09
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -97.2688 days.

 Limitations

  • The company has shown a poor profit growth of -54.8234231961209% for the Past 3 years.
  • The company has shown a poor revenue growth of 14.5244055545919% for the Past 3 years.
  • Company has a poor ROE of 2.2575% over the past 3 years.
  • Promoter pledging has increased from 4.99499824277555% to 5.7% in 1 quarter.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 44.2934.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 314.35 306.67 312.51 324.38 327.09
Total Expenditure 261.82 248.63 270.19 265.49 277.24
Operating Profit 52.53 58.04 42.32 58.89 49.85
Other Income 10.07 10.24 5.29 9.46 7.94
Interest 19.79 20.16 21.27 22.5 24.3
Depreciation 26.56 27.13 27.9 29.05 28.25
Exceptional Items 0 0 -34.82 0 0
Profit Before Tax 16.25 20.99 -36.38 16.8 5.24
Tax 3.49 4.96 0.95 6.65 1.79
Profit After Tax 12.76 16.03 -37.33 10.15 3.45
Adjusted EPS (Rs) 0.92 1.15 -2.68 0.73 0.25

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 608.86 849.83 1005.57 1170.66 1276.52
Total Expenditure 535.4 702.96 836.51 970.07 1065.17
Operating Profit 73.47 146.87 169.06 200.59 211.35
Other Income 24.02 12.42 22.02 16.2 38.58
Interest 62.86 42.8 41.49 50.07 84.14
Depreciation 86.58 88.36 88.97 96.92 111.39
Exceptional Items -153.1 52.91 -3 -16.1 -34.82
Profit Before Tax -205.06 81.04 57.62 53.7 19.58
Tax -13.51 42.79 17.43 20.9 16.05
Net Profit -191.55 38.25 40.19 32.8 3.53
Adjusted EPS (Rs.) -15.28 2.75 2.89 2.35 0.25

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 125.36 139.01 139.12 139.29 139.42
Total Reserves 798.42 958.68 1006.01 1042.18 1051.91
Borrowings 147.13 82.03 112.72 273.91 303.57
Other N/C liabilities 226.35 248.75 251.07 369.62 486.07
Current liabilities 249.93 215.08 220.8 414.11 622.84
Total Liabilities 1547.19 1643.55 1729.71 2239.11 2603.8
Assets
Net Block 745.17 773.84 787.63 974.1 1038.05
Capital WIP 27.61 4.82 9.22 36.49 22.61
Intangible WIP 0 0 0 0 0
Investments 365.66 438.66 474.93 506.33 695.75
Loans & Advances 73.58 63.13 77.77 133.41 148.25
Other N/C Assets 7.19 6.95 7.64 57.1 58.69
Current Assets 327.99 356.16 372.52 531.69 640.45
Total Assets 1547.19 1643.55 1729.71 2239.11 2603.8
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -205.06 81.04 57.62 53.7 19.58
Adjustment 284.92 79.09 150.49 173.81 226.57
Changes in Assets & Liabilities -49.41 -21.02 -60.47 14.49 -81.64
Tax Paid 40.43 -14.72 -17.25 -33.11 -18.56
Operating Cash Flow 70.89 124.4 130.4 208.89 145.95
Investing Cash Flow -245.62 48.65 -137.7 -253.94 -347.32
Financing Cash Flow 235.92 -41.04 -41.71 95.92 -41.55
Net Cash Flow 61.19 132 -49.02 50.87 -242.92

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 71.25 71.23 71.23 71.22 62.46
aagnika ajaikumar 0.23 0.23 0.23 0.23 0.23
asmitha ajaikumar 0.23 0.23 0.23 0.23 0.23
catalyst trusteeship limi... - - - - 0.18
dr. b. s. ajaikumar - - - - 10.40
hector asia holdings ii p... - - - - 51.41
aceso company pte. ltd. 60.38 60.36 60.35 60.35 -
ajaikumar b s - 10.40 - 10.40 -
b s ajaikumar 10.40 - 10.40 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 28.75 28.77 28.77 28.78 37.54
aceso company pte. ltd. - - - - 8.76
clarus capital i 1.39 1.71 1.75 1.82 1.86
motilal oswal s&p bse hea... - - 2.29 3.11 3.13
nippon life india trustee... - 3.16 3.16 2.51 2.51
tata india consumer fund - - - - 3.65
tata india pharma & healt... 3.35 - - 3.42 -
icici prudential pharma h... 2.17 2.17 1.02 - -
tata mutual fund - tata s... - 3.35 3.35 - -
international finance cor... 2.35 2.34 - - -
nippon life india trustee... 3.09 - - - -
zafar ahmadullah 1.55 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit CARE
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research Geojit
Research HDFC Securities
Research Edelweiss
Research HDFC Securities
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY25
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY21
Concall Q2FY24
Concall Q2FY21
Concall Q1FY24
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY23
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

HealthCare Global Enterprises informs about compliances certificate 17 Oct, 4:46 PM HealthCare Global Enterprises informs about disclosures 15 Sep, 4:59 PM HealthCare Global Enterprises informs about change in management 13 Sep, 12:25 PM HealthCare Global Enterprises informs about press release 3 Sep, 12:26 PM HealthCare Global Enterprises informs about newspaper advertisement 2 Aug, 2:41 PM HealthcareGlobal - Quaterly Results 1 Aug, 5:32 PM HealthcareGlobal - Quaterly Results 1 Aug, 5:32 PM HealthcareGlobal - Quaterly Results 1 Aug, 5:32 PM HealthCare Global Enterprises informs about disclosure 10 Jun, 3:27 PM HealthCare Global Enterprises informs about updates 10 Jun, 3:06 PM HealthcareGlobal - Quaterly Results 24 May, 7:24 PM HealthcareGlobal - Quaterly Results 24 May, 7:24 PM HealthCare Global Enterprises informs about trading window closure 29 Mar, 2:48 PM HealthCare Global Enterprises informs about newspaper publication 29 Mar, 12:52 PM HealthCare Global Enterprises informs about disclosures 19 Mar, 4:59 PM HealthCare Global Enterprises informs about disclosure 11 Mar, 11:24 AM HealthCare Global Enterprises informs about transcript of earnings call 6 Mar, 12:45 PM HealthCare Global Enterprises informs about conference call 25 Feb, 1:09 PM KKR to acquire controlling stake in HCG 24 Feb, 11:41 AM HealthcareGlobal - Quaterly Results 14 Feb, 1:04 PM HealthcareGlobal - Quaterly Results 14 Feb, 1:04 PM HealthcareGlobal - Quaterly Results 14 Feb, 1:04 PM HealthCare Global Enterprises informs about audio recording of earnings call 11 Nov, 4:30 PM Healthcare Global Enterprises to acquire oncology business of HCG NCHRI Oncology LLP 11 Nov, 3:28 PM HealthcareGlobal - Quaterly Results 9 Nov, 6:05 PM HealthcareGlobal - Quaterly Results 9 Nov, 6:05 PM HealthcareGlobal - Quaterly Results 9 Nov, 6:05 PM HealthCare Global Enterprises informs about scrutinizers report & voting results 9 Sep, 5:32 PM HealthCare Global Enterprises submits analyst meet intimation 29 Aug, 12:31 PM HealthcareGlobal - Quaterly Results 8 Aug, 5:31 PM HealthcareGlobal - Quaterly Results 8 Aug, 5:31 PM HealthcareGlobal - Quaterly Results 8 Aug, 5:31 PM HealthCare Global Enterprises informs about earnings call 25 Jul, 5:32 PM HealthCare Global Enterprises informs about board meeting 25 Jul, 12:23 PM HCG to acquire controlling stake in Mahatma Gandhi Cancer Hospital & Research Institute 28 Jun, 2:33 PM HealthCare Global Enterprises informs about press release 30 May, 10:28 AM HealthcareGlobal - Quaterly Results 29 May, 7:07 PM HealthcareGlobal - Quaterly Results 29 May, 7:07 PM HealthCare Global Enterprises informs about Acquisition 9 Mar, 2:42 PM HealthCare Global Enterprises submits analyst meet intimation 26 Feb, 4:28 PM HealthcareGlobal - Quaterly Results 8 Feb, 4:39 PM HealthcareGlobal - Quaterly Results 8 Feb, 4:39 PM HealthcareGlobal - Quaterly Results 8 Feb, 4:39 PM HealthCare Global Enterprises informs about newspaper publication 30 Dec, 11:00 AM HealthCare Global Enterprises informs about earnings call transcript 18 Nov, 12:03 PM HealthcareGlobal - Quaterly Results 9 Nov, 5:18 PM HealthcareGlobal - Quaterly Results 9 Nov, 5:18 PM HealthCare Global Enterprises informs about disclosure 4 Oct, 5:27 PM HealthCare Global Enterprises completes acquisition of Oncology & Radiation business 4 Oct, 4:29 PM HealthCare Global Enterprises informs about press release 11 Aug, 12:24 PM

HealthcareGlobal Stock Price Analysis and Quick Research Report. Is HealthcareGlobal an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse HealthcareGlobal. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). HealthcareGlobal has a PE ratio of -1343.25215162058 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. HealthcareGlobal has ROA of 0.1457% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. HealthcareGlobal has a Current ratio of 1.0283.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. HealthcareGlobal has a ROE of 0.3024%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. HealthcareGlobal has a Debt to Equity ratio of 0.5571 which means that the company has low proportion of debt in its capital.

  • Sales growth: HealthcareGlobal has reported revenue growth of 9.0428% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of HealthcareGlobal for the current financial year is 16.5565627200806%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for HealthcareGlobal is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of HealthcareGlobal is Rs -0.5461. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of HealthcareGlobal in Ticker for free. Also, one can get the intrinsic value of HealthcareGlobal by using Valuation Calculators, which are available with a Finology ONE subscription. 

HealthcareGlobal FAQs

Q1. What is HealthcareGlobal share price today?
Ans: The current share price of HealthcareGlobal is Rs 733.55.

Q2. What is the market capitalisation of HealthcareGlobal?
Ans: HealthcareGlobal has a market capitalisation of Rs 10343.0623355 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of HealthcareGlobal?
Ans: The PE ratio of HealthcareGlobal is -1343.25215162058 and the P/B ratio of HealthcareGlobal is 8.81009915640193, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of HealthcareGlobal share?
Ans: The 52-week high share price of HealthcareGlobal is Rs 744.5, and the 52-week low share price of HealthcareGlobal is Rs 404.8.

Q5. Does HealthcareGlobal pay dividends?
Ans: Currently, HealthcareGlobal does not pay dividends. Dividend yield of HealthcareGlobal is around 0%.

Q6. What are the face value and book value of HealthcareGlobal shares?
Ans: The face value of HealthcareGlobal shares is Rs 10, while the book value per share of HealthcareGlobal is around Rs 83.2624. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of HealthcareGlobal?
Ans: HealthcareGlobal has a total debt of Rs 651.289 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of HealthcareGlobal?
Ans: The ROE of HealthcareGlobal is 0.3024% and ROCE of HealthcareGlobal is 6.0339%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is HealthcareGlobal a good buy for the long term?
Ans: The HealthcareGlobal long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is HealthcareGlobal undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the HealthcareGlobal appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check HealthcareGlobal’s financials?
Ans: You can review HealthcareGlobal’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about HealthcareGlobal

Healthcare Global Enterprises Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Healthcare Global Enterprises Ltd. (HCG) is a renowned healthcare provider offering comprehensive cancer care services. The company operates a network of state-of-the-art cancer centers across India, focusing on advanced medical treatments, cutting-edge technology, and compassionate patient care. With a strong commitment to excellence, HCG has emerged as a trusted name in the healthcare sector.

Healthcare Global Enterprises Ltd. - Share Price

At our website, you can access real-time updates on the share price of Healthcare Global Enterprises Ltd. Our pre-built screening tools enable investors to track the performance of the stock and make informed investment decisions. Stay updated with the latest market trends and fluctuations in the share price to optimize your investment strategy.

Healthcare Global Enterprises Ltd. - Balance Sheet

The balance sheet of Healthcare Global Enterprises Ltd. provides valuable insights for long-term stock investors. By analyzing the company's financial position, investors can assess its assets and liabilities, evaluate its debt levels, and gauge its overall financial stability. Utilize our premium features, such as fair value calculation using tools like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, to delve deeper into the balance sheet and make informed investment choices.

Healthcare Global Enterprises Ltd. - Annual Report

As a long-term investor, it is crucial to review the annual reports of companies for a comprehensive understanding of their performance, future plans, and financial health. At our website, you can easily access and download the annual reports of Healthcare Global Enterprises Ltd. These reports provide detailed information about the company's operations, key achievements, corporate governance practices, and much more. Stay updated with the company's progress by studying its annual reports.

Healthcare Global Enterprises Ltd. - Dividend

Dividends play a significant role in long-term stock investing, providing regular income streams and reflecting the company's financial success. Stay informed about Healthcare Global Enterprises Ltd.'s dividend policies, payout history, and future dividend prospects. Our website offers detailed dividend information to help investors evaluate the sustainability and attractiveness of the company's dividend payments.

Healthcare Global Enterprises Ltd. - Quarterly Results

Analyzing the quarterly results of Healthcare Global Enterprises Ltd. empowers investors to assess the company's financial performance and track its progress over time. Our website keeps investors posted on the latest quarterly results, enabling effective decision-making and ensuring an informed investment strategy. Use our premium features to perform in-depth analysis, along with pre-built screening tools to evaluate key financial indicators.

Healthcare Global Enterprises Ltd. - Stock Price

Monitor the stock price of Healthcare Global Enterprises Ltd. with real-time updates provided on our website. Stay informed about the fluctuations in the stock market and make calculated investment decisions. Leverage our pre-built screening tools to analyze key performance indicators and evaluate the stock's potential for long-term growth.

Healthcare Global Enterprises Ltd. - Price Chart

Our website presents a comprehensive price chart for Healthcare Global Enterprises Ltd., ensuring easy analysis of historical price movements. Visualize the stock's performance over time and identify patterns or trends that could impact your investment strategy. Utilize our pre-built screening tools to study key technical indicators aligned with the price chart, enhancing your understanding of the stock's trajectory.

Healthcare Global Enterprises Ltd. - News

Access the latest news and updates related to Healthcare Global Enterprises Ltd. on our website. Stay informed about relevant industry developments, company announcements, mergers and acquisitions, and regulatory changes. Keeping track of the latest news allows investors to make timely decisions based on current information and industry trends.

Healthcare Global Enterprises Ltd. - Concall Transcripts

Concall transcripts provide valuable insights by capturing the discussions and Q&A sessions during company conference calls. At our website, you can easily download the concall transcripts of Healthcare Global Enterprises Ltd., gaining access to detailed information about the company's strategies, performance indicators, and future plans. Analyze these transcripts to stay updated on management's perspectives, industry trends, and key insights.

Healthcare Global Enterprises Ltd. - Investor Presentations

Investor presentations offer a comprehensive overview of Healthcare Global Enterprises Ltd.'s operations, growth strategies, and financial performance. These presentations provide investors with essential information to assess the company's potential and make informed investment decisions. At our website, you can conveniently access and download investor presentations to stay updated on the company's progress.

Healthcare Global Enterprises Ltd. - Promoters

Dive deeper into the ownership structure and key stakeholders of Healthcare Global Enterprises Ltd. by examining the promoter details. Our website provides insights into the company's promoters and their shareholdings, empowering investors to understand the background and influence of these key individuals or entities.

Healthcare Global Enterprises Ltd. - Shareholders

Understanding the shareholders of Healthcare Global Enterprises Ltd. is vital for long-term investors. Analyze the major shareholders, institutional investors, and their holdings to gain insights into market sentiment and investor confidence. Our pre-built screening tools facilitate the evaluation of key shareholder data, allowing investors to make informed decisions based on ownership patterns.

Note: This content is purely fictional and created to demonstrate the format and guidelines provided. The information provided is not based on real data or facts about Healthcare Global Enterprises Ltd.  

Healthcare Global Enterprises' Balance Sheet Analysis

Healthcare Global Enterprises' Share Capital Development

Healthcare Global Enterprises has shown a modest but consistent increase in its share capital from Rs. 88.69 Cr. in March 2020 to Rs. 139.29 Cr. by March 2024. This gradual increase highlights the company's strategy for growth and possible equity funding to support its expansion or operations.

Reserves Growth in Healthcare Global Enterprises

The total reserves of Healthcare Global Enterprises have witnessed a significant surge from Rs. 525.82 Cr. in March 2020 to Rs. 1,049.30 Cr. in March 2024. This robust growth in reserves indicates a solid accumulation of retained earnings, which could be a good sign of the company's profitability and financial health.

Healthcare Global Enterprises' Debt Management

The company's borrowings have seen fluctuations over the years. From Rs. 314.95 Cr. in March 2020, it dipped to Rs. 82.03 Cr. by March 2022, showing a strong debt reduction. However, by March 2024, the borrowings increased again to Rs. 260.53 Cr., reflecting a dynamic approach to leveraging.

Asset Acquisition of Healthcare Global Enterprises

The total assets of Healthcare Global Enterprises have significantly grown from Rs. 1,753.61 Cr. in March 2020 to Rs. 2,187.89 Cr. by March 2024. This increase is particularly noticeable in the net block and current assets, implying an expansion in operational assets and liquidity.

This data is an analysis for the Standalone Balance Sheet of the company. Such analytical insights are essential for investors considering diversifications within the healthcare sector or looking into healthcare stocks in the NSE/BSE indices.

Read More
X